ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 166 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2018. The put-call ratio across all filers is 9.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $222,000 | -9.4% | 4,800 | +4.3% | 0.00% | 0.0% |
| Q3 2017 | $245,000 | -67.9% | 4,600 | -59.2% | 0.00% | -83.3% |
| Q1 2017 | $764,000 | +107.0% | 11,284 | +117.0% | 0.01% | +100.0% |
| Q3 2016 | $369,000 | +44.7% | 5,200 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $255,000 | -19.6% | 5,200 | +4.0% | 0.00% | -33.3% |
| Q1 2016 | $317,000 | -91.1% | 5,000 | -86.5% | 0.00% | -84.2% |
| Q3 2015 | $3,578,000 | +512.7% | 37,150 | +551.8% | 0.02% | +375.0% |
| Q2 2015 | $584,000 | – | 5,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |